摘要
目的:观察半夏白术天麻汤加减治疗交感神经型颈椎病临床疗效。方法:将确诊为交感型颈椎病痰浊困阻型患者102例患者纳入研究并随机分为2组,对照组50例采用牵引治疗,并予甲钴胺片营养神经;观察组52例在对照组治疗方案的基础上联合半夏白术天麻汤加减口服治疗,治疗3月为1疗程。比较2组临床疗效。结果:治疗后,2组症状头晕、颈部疼痛、恶心、耳鸣积分分别与治疗前比较,差异均有统计学意义(P<0.05);且2组间比较,差异均有统计学意义(P<0.05);治疗后,观察组左椎动脉、右椎动脉、基底动脉血流速度增快或减慢患者各自血流速度情况分别与治疗前比较,差异均有统计学意义(P<0.05),且2组间比较,差异均有统计学意义(P<0.05);2组间临床疗效比较,差异有统计学意义(P<0.05)。结论:半夏白术天麻汤加减治疗交感神经型颈椎病疗效良好,可更好地改善临床症状,并双向调节椎动脉血流速度,值得临床运用。
Objective：To observe the clinical effect of modified Banxia Baizhu Tianma tang for sympathetic nervous cervical spondylosis. Methods：Selected 102 patients who were diagnosed as sympathetic nervous cervical spondylosis of phlegm stasis syndrome as study objects,and divided them two groups randomly. The control was given traction treatment and mecobalamin tablets for nerve as nutrition. The observation group was given oral modified Banxia Baizhu Tianma tang based on the treatment of the control group. One course of treatment lasted for three months. Compared clinical effect of the two groups after treatment. Results：After treatment,compared dizziness,cervical pain,nausea and tinnitus scores of the two groups with those before treatment, the difference being significant（P〉0.05）, and the difference between the two groups also being significant（P〈0.05）. After treatment,blood flow rate of left vertebral artery,right vertebral artery,basilar artery of the observation group were faster or slower than those before treatment, and the difference between the two groups also being significant. Compared clinical effect of the two groups, the difference being significant（P〈0.05）.Conclusion：modified Banxia Baizhu Tianma tang has good clinical efficacy in treating sympathetic nervous cervical spondylosis,which can better improve clinical symptom, has bi-directional regulation effect on vertebral artery speed of vertebral artery,and it is worth of clinical application.
出处
《新中医》
CAS
2017年第5期68-71,共4页
New Chinese Medicine
关键词
交感神经型颈椎病
半夏白术天麻汤
椎动脉血流
疾病复发率
Sympathetic nervous cervical spondylosis
Banxia Baizhu Tianma tang
Blood flow of vertebral artery
Desease recurrence rate
